U.K. firm Slaughter and May is advising on a deal that could see Africa acquire up to 400 million doses of a new COVID-19 vaccine.
The firm is leading on the establishment of the African Vaccine Acquisition Trust (AVAT), which according to a new agreement will purchase up to 400 million single-shot COVID-19 vaccine doses from U.S. pharma major Johnson & Johnson. The doses will serve the African Union (AU).
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
